• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » American Association for Cancer Research, Debbie's Dream Foundation partner

American Association for Cancer Research, Debbie's Dream Foundation partner

January 13, 2014
CenterWatch Staff

The American Association for Cancer Research (AACR) and Debbie's Dream Foundation: Curing Stomach Cancer (DDF) have announced a new fellowship opportunity in gastric cancer research.

The Debbie's Dream Foundation-AACR Gastric Cancer Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct gastric cancer research and to establish a successful career path. The proposed research may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to gastric cancer.

Headquartered in Davie, Fla. and helping patients, families and caregivers internationally, DDF is an international leader in raising awareness, advancing funding for stomach cancer research and supporting those affected by all forms of stomach cancer through its many free programs.

"The overall five-year survival rate for people diagnosed with stomach cancer in the U.S. is less than 30%, so the AACR is pleased to be partnering with Debbie's Dream Foundation to offer a fellowship in gastric cancer research," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "We know that one reason the overall survival rate is so low is that gastric cancer is predominantly diagnosed at an advanced stage, making it extremely hard to treat. This new funding opportunity will help to foster new research and accelerate progress against this disease, which is the third leading cause of cancer death worldwide."

"We are delighted to be collaborating with the AACR on this grant opportunity. This partnership will allow the grant to be publicized to a larger audience, thus bringing the best and brightest minds into stomach cancer research. Collaboration is one of the keys to advancing gastric cancer treatment options," said Madelyn Herzfeld, DDF board member and DDF grant committee chair.

"We have been working tirelessly to fund research indirectly through advocacy and we are thrilled to now fund gastric cancer research directly," said Debbie Zelman, president and founder of DDF. "With this grant, we are achieving our mission and we are one step closer to our ultimate goal of making the cure for stomach cancer a reality."

The fellowship will provide $50,000 over a one-year term, which will begin July 1.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing